Translate the text from Welsh to English.



 
Mae’r Ysgrifennydd Iechyd, Vaughan Gething, wedi lansio’r Strategaeth Genomeg ar gyfer Meddygaeth Fanwl, sydd wedi’i chynllunio i sicrhau bod modd i bobl trwy Gymru gael mynediad at ddiagnosis cyflymach a chywirach. Gwneir hynny trwy alluogi clinigwyr i ddeall clefyd unigol claf trwy ddadansoddi ei enynnau. Bydd hyn yn eu helpu i ddatblygu triniaethau sydd wedi’u teilwra ar gyfer unigolion, yn hytrach na thriniaeth a gynlluniwyd ar gyfer y boblogaeth yn gyffredinol.  
  
Mae’r strategaeth hefyd yn amlinellu cynlluniau i ddefnyddio’r technegau diweddaraf ar gyfer gwella dulliau o ragfynegi clefydau a meithrin gwell dealltwriaeth o ddigwyddiadau pan geir nifer o achosion o glefyd.     
  
Yn ogystal, bydd y strategaeth yn datblygu gwaith ymchwil mewn geneteg a genomeg, yn hybu gwybodaeth a sgiliau’r gweithlu oddi mewn ac oddi allan i’r GIG ac yn creu partneriaethau strategol mewn genomeg ar gyfer meddygaeth fanwl.   
  
Dywedodd yr Ysgrifennydd Iechyd, Vaughan Gething: 


> “Mae technolegau genetig a genomig yn caniatáu inni feithrin dealltwriaeth lawer manylach o’r cysylltiad rhwng ein genynnau a’n hiechyd.
> 
> “Mae gan y strategaeth rwy’n ei lansio heddiw botensial i chwyldroi meddygaeth ac iechyd y cyhoedd; mae’n nodi proses o droi oddi wrth leihadaeth (reductionism) a symud tuag at gyfnod newydd o feddygaeth fanwl.
> 
> “Bydd yn galluogi cleifion trwy Gymru i fanteisio ar y dechnoleg hon ac i gwtogi eu ‘siwrnai ddiagnostig’. Mae mwy i’n strategaeth na dim ond darparu canlyniadau profion newydd; mae’n ymwneud hefyd â’r gofal a’r cymorth sydd eu hangen ar gleifion er mwyn cael gafael ar y gwasanaethau hyn, ac mae’n ymwneud â darparu’r wybodaeth angenrheidiol fel y gallant wneud y penderfyniad cywir iddyn nhw’u hunain a’u cyflwr, a hynny ar sail yr wybodaeth fwyaf cywir, cyfredol a chytbwys sydd ar gael.
> 
> “Er enghraifft, mae ein dealltwriaeth o sail enynnol canser bellach yn helpu i ddarparu therapïau sydd wedi’u teilwra ar gyfer cleifion. Yn achos canser yr ysgyfaint, mae pedwar dangosydd genynnol wedi’u dynodi, sy’n caniatáu i glinigwyr roi’r triniaethau sydd fwyaf tebygol o rwystro tiwmorau rhag tyfu,  lleihau eu maint ac ymestyn ansawdd a hyd bywyd y claf.”
> 
> Cefnogir y Strategaeth Genomeg ar gyfer Meddygaeth Fanwl gan £6\.8m o arian gan Lywodraeth Cymru a chafodd ei datblygu gan y tasglu genomeg, sy’n cynnwys Llywodraeth Cymru, GIG Cymru, y Trydydd Sector a sefydliadau addysg uwch.







Translation:


 
Health Secretary, Vaughan Gething, has launched a new Genomics for Precision Medicine Strategy, which is designed to ensure people across Wales have access to quicker, more accurate diagnosis by enabling clinicians to better understand a patient’s individual disease by analysing their genes. This will help clinicians develop targeted treatments for individuals, rather than provide treatment that’s designed for the population as a whole.  
  
It also sets out plans to apply the latest techniques for improved disease prediction and gain a better understanding of disease outbreaks.  
  
In addition, the strategy will develop research in genetics and genomics, grow knowledge and skills amongst the NHS and non\-NHS workforce and build strategic partnerships in genomics for precision medicine.  
  
Health Secretary Vaughan Gething said:


> “New genetic and genomic technologies are allowing us to develop a much more detailed understanding of the link between our genes and our health.
> 
> “The strategy I’m launching today has the potential to revolutionise medicine and public health; it marks a move away from reductionism and moves us towards a new era of precision medicine. 
> 
> “It will enable patients across Wales to access this new technology and shorten their ‘diagnostic odyssey’. Our strategy is not just about providing new test results; it is also about the care and support that patients need in accessing these services and providing them with the information that they need to make the right decision for themselves and their condition, armed with the most accurate, up\-to\-date and considered information available.
> 
> “For instance, our understanding of the genetic basis of cancer now supports the provision of targeted therapies to patients. In lung cancer, four genetic markers have been identified and these allow clinicians to give the treatments most likely to stop the growth of tumours, shrink them and lengthen quality and duration of life.”  
> 
> The Genomics for Precision Medicine Strategy is underpinned by £6\.8m Welsh Government funding and was developed by the genomics taskforce, which includes the Welsh Government, NHS Wales, the Third Sector and higher education institutions.